Recombinant activated factor VII use in critically ill infants with active hemorrhage

Journal of Pediatric Surgery

Volumn 43, Issue 12, 2008, Pages 2235-2238

  Jen, Howard ^a   Shew, Stephen ^a  

^a CHILDREN S HOSPITAL LOS ANGELES   (United States)

Author keywords

Bleeding; Factor VII; Hemorrhage; Infants; Transfusion

Indexed keywords

RECOMBINANT BLOOD CLOTTING FACTOR 7A;

ARTICLE; BLOOD TRANSFUSION; CLINICAL ARTICLE; CONGENITAL HEART DISEASE; CONTROLLED STUDY; CRITICALLY ILL PATIENT; CRYOPRECIPITATE; DRUG EFFICACY; DRUG SAFETY; ERYTHROCYTE; FEMALE; GASTROJEJUNOSTOMY; HEART SURGERY; HEMOPHILIA; HUMAN; INFANT; LIVER TRANSPLANTATION; MALE; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; SINGLE DRUG DOSE; THROMBOCYTE; VEIN THROMBOSIS;

BLOOD COMPONENT TRANSFUSION; CRITICAL CARE; CRITICAL ILLNESS; FACTOR VIIA; FACTOR VIII; FEMALE; FIBRINOGEN; HEMORRHAGE; HEMOSTATICS; HUMANS; INFANT; MALE; POSTOPERATIVE HEMORRHAGE; RECOMBINANT PROTEINS; RETROSPECTIVE STUDIES; VENOUS THROMBOSIS;

EID: 56649117424     PISSN: 00223468     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpedsurg.2008.08.053     Document Type: Article

References (14)

1. Hedner U., and Kisiel W. Use of human factor VIIa in the treatment of two hemophilia A patients with high-titer inhibitors. J Clin Invest 71 (1983) 1836-1841
2. http://www.fda.gov/CBER/label/viianov101306LB.pdf
3. Ranucci M., Isgro G., Soro G., et al. Efficacy and safety of recombinant activated factor VII in major surgical procedures: systematic review and meta-analysis of randomized clinical trails. Arch Surg 143 (2008) 296-304
4. Von Heymann C., Jonas S., Spies C., et al. Recombinant activated factor VIIa for the treatment of bleeding in major abdominal surgery including vascular and urological surgery: a review and meta-analysis of published data. Crit Care 12 (2008) R14
5. Filan P., Mills J., Clarnette T., et al. Spontaneous liver hemorrhage during laparotomy for necrotizing enterocolitis: a potential role for recombinant factor VIIa. J Pediatr 147 (2005) 857-859
6. Grizelj R., Vukovic J., Filipovic-Grcic B., et al. Successful use of recombinant activated FVII and aminocaproic acid in four neonates with life-threatening hemorrhage. Blood Coagul Fibrinolysis 17 (2006) 413-415
7. Abdullah F., Hunter C., Hargrove C., et al. Recombinant factor VIIa for treatment of massive liver fracture in a premature infant. J Pediatr Surg 41 (2006) 1764-1767
8. Brady K., Easley R., and Tobias J. Recombinant activated factor VII (rFVIIa) treatment in infants with hemorrhage. Paediatr Anaesth 16 (2006) 1042-1046
9. Cetin H., Yalaz M., Akisu M., et al. The use of recombinant activated factor VII in the treatment of massive pulmonary hemorrhage in a preterm infant. Blood Coagul Fibrinolysis 17 (2006) 213-216
10. Chuansmrit A., Nuntnarumit P., Okascharoen C., et al. The use of recombinant activated factor VII to control bleeding in a preterm infant undergoing exploratory laparotomy. Pediatrics 110 (2002) 169-171
11. Ekert H., Brizard C., Eyers R., et al. Elective administration in infants of low-dose recombinant activated factor VII (rFVIIa) in cardiopulmonary bypass surgery for congenital heart disease does not shorten time to chest closure or reduce blood loss and need for transfusion: a randomized, double-blind, parallel group, placebo-controlled study of rFVIIa and standard haemostatic replacement therapy versus standard haemostatic replacement therapy. Blood Coagul Fibrinolysis 17 (2006) 389-395
12. Erhardtsen E. Pharmacokenetics of recombinant activated factor VIIa (rFVIIa). Semin Thromb Hemost 26 (2000) 385-391
13. Villar A., Aronis S., Morfini M., et al. Pharmacokinetics of activated recombinant coagulation factor VII (NovoSeven) in children vs. adults with haemophilia A. Haemophilia 10 (2004) 352-359
14. http://www.fda.gov/medWatch/SAFETY/2005/novose_pi_fa.pdf